Consolidated Statement of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash flows from operating activities:
Net income/(loss) attributable to the Company	$ 39,137	$ (10,970)	$ 5,231
Adjustments to arrive at net income/(loss) from continuing operations
Net income attributable to noncontrolling interests	(3,216)	(2,614)	(3,649)
Net pre-tax (gain)/loss from operating activities of discontinued operations	(10,460)	(6,665)	(1,574)
Net pre-tax gain on sale of discontinued operations	0	0	(3,082)
Tax expense from discontinued operations	4,361	2,936	12,161
Net income/(loss) from continuing operations	36,254	(12,085)	16,385
Adjustments to reconcile net income/(loss) from continuing operations to net cash provided by/(used in) operating activities:
Depreciation and amortization	18,287	17,595	17,904
Net income attributable to noncontrolling interests	(3,216)	(2,614)	(3,649)
Equity issued as compensation	6,867	5,528	6,943
Impairment of goodwill and intangibles	0	0	1,699
Provision for loan losses	13,160	87,178	44,959
Loans originated for sale	(156,441)	(210,447)	(288,880)
Proceeds from sale of loans held for sale	154,480	214,523	290,903
Gain on the repurchase of debt	(4,230)	0	(18,739)
Deferred income tax expense/(benefit)	(7,798)	25,981	6,230
Net decrease/(increase) in other operating activities	6,829	(1,535)	72,466
Net cash provided by/(used in) operating activities of continuing operations	79,788	72,162	133,761
Net cash provided by/(used in) operating activities of discontinued operations	6,099	3,729	111,507
Net cash provided by/(used in) operating activities	85,887	75,891	245,268
Investment securities available for sale:
Purchases	(735,262)	(785,644)	(741,073)
Sales	162,728	434,919	304,822
Maturities, redemptions, and principal payments	521,245	435,792	345,766
Purchases	0	(7,279)	(8,027)
Maturities, sales, and principal payments	0	9,268	8,026
(Investments)/distributions in trusts, net	231	(547)	(1,092)
(Purchase)/ redemption of Federal Home Loan Banks stock	2,132	1,644	0
Net increase in portfolio loans	(208,512)	(278,130)	(241,493)
Proceeds from recoveries of loans previously charged off	11,975	9,519	1,328
Proceeds from sale of OREO	24,513	21,235	24,979
Proceeds from sale of portfolio loans	0	18,434	0
Proceeds from sale and repayments of non-strategic loan portfolio, net of advances	1,000	4,323	21,367
Capital expenditures, net of sale proceeds	(8,969)	(4,406)	(5,587)
Cash received from dispositions/ (paid for acquisitions, including deferred acquisition obligations, net of cash acquired)	2,752	(31,525)	(2,744)
Cash received from sale of discontinued operations, net of cash divested	0	0	79,103
Net cash provided by/(used in) investing activities - continuing operations	(226,167)	(172,397)	(214,625)
Net cash provided by/(used in) investing activities - discontinued operations	0	0	39,626
Net cash provided by/(used in) investing activities	(226,167)	(172,397)	(174,999)
Cash flows from financing activities:
Net increase in deposits	43,685	231,507	506,307
Net (decrease)/increase in securities sold under agreements to repurchase and other	(127,807)	15,221	(50,464)
Net (decrease)/increase in short-term Federal Home Loan Bank borrowings	(10,000)	10,000	(134,300)
Advances of long-term Federal Home Loan Bank borrowings	119,313	177,040	30,777
Repayments of long-term Federal Home Loan Bank borrowings	(163,168)	(166,370)	(86,937)
Repurchase of debt	(6,988)	0	(76,939)
Repurchase of Series C Preferred stock	0	(154,000)	0
Dividends paid to common share holders	(3,089)	(2,900)	(2,688)
Dividends paid to preferred shareholders	(290)	(3,099)	(7,862)
Tax deficiency from certain stock compensation awards	(1,706)	(1,613)	0
Proceeds from stock option exercises	205	474	341
Proceeds from issuance of common stock, net	1,244	34,077	769
Other equity adjustments	(1,657)	3,148	(6,982)
Net cash provided by/(used in) financing activities - continuing operations	(150,258)	143,485	172,022
Net cash provided by/(used in) financing activities - discontinued operations	0	0	(76,106)
Net cash provided by/(used in) financing activities	(150,258)	143,485	95,916
Net increase/(decrease) in cash and cash equivalents	(290,538)	46,979	166,185
Cash and cash equivalents at beginning of year	494,439	447,460	281,275
Cash and cash equivalents at end of period	203,901	494,439	447,460
Supplementary schedule of non-cash investing and financing activities:
Cash paid for interest	51,802	72,998	102,126
Cash paid for income taxes, net of (refunds received)	11,300	11,621	(76,089)
Change in unrealized gain/ (loss) on securities available for sale, net of tax	3,236	(3,207)	(1,785)
Change in unrealized gain/ (loss) on cash flow hedges, net of tax	(1,735)	(3,021)	(1,283)
Change in unrealized gain/ (loss) on other, net of tax	745	4	(831)
Held to maturity investments transferred to available for sale or other investments at fair value	2,515	0	0
Available for sale investments transferred to other investments at fair value	750	0	0
Loans transferred into other real estate owned from held for sale or portfolio	11,118	19,863	28,418
Loans charged-off	(27,424)	(66,739)	(41,934)
Loans transferred into/(out of) held for sale from/(to) portfolio	(526)	18,360	(1,744)
Equity issued for acquisitions, including deferred acquisition obligations	$ 4,290	$ 3,303	$ 10,625